ObesityNCT02566317
Stand & Move at Work
A study testing Sit-Stand workstation and Move in people with Obesity and Hypertension, run by Arizona State University at 2 sites in United States.
Trial summary
A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Obesity, Hypertension, Diabetes
- What is being tested?
- Sit-Stand workstation and Move
- Type of treatment
- Medical device, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 630 participants
- Where
- 2 sitesUnited States
- Study dates
- 15 Jan 2016to 15 Dec 2018
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Worksite-level inclusion criteria:
- Size: Small to moderate size worksite (20-60 employees)
- Schedule: >80% of employees full time
- Occupation: Seated office work, primarily computer- and- telephone-based work, little movement or walking
- Wellness environment: Not currently undergoing a wellness program aimed at increasing activity at work
- Workstations: Willing to have sit-stand workstations installed at a worksite
Show all 13Show fewer
- Willing to be randomized: Willing to be randomized to either intervention conditions
- Member-level inclusion criteria:
- Age: 18 years and older
- Health status: Generally good health and able to safely increase LPA and reduce sitting time
- Employment status: Any sedentary job, sitting most of the say, little standing or walking
- Occupation: Traditional sitting desk, willing to have a sit-stand workstation installed at desk
- Workstation: traditional sitting desk;willing to have a sit-stand workstation installed at desk
Who cannot join
- contraindication to prolonged standing at work
Trial locations and contacts
2 sites in 1 country.
United States2 sites
University of Minnesota
Minneapolis, Minnesota, 55455
Arizona State University
Tempe, Arizona, 85281
About this study
Official title: Stand & Move at Work: A Group Randomized Trial
A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.
Read the detailed description
With traditional approaches to increasing MVPA (moderate to vigorous physical activity) in the workplace being unsustainable due to the requirement of deliberate and dedicated time away from work, this group-randomized trial will test the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity (LPA) in a highly generalizable sample of office worksites using a multi-level intervention with high potential for dissemination.
- Conditions
- Obesity, Hypertension, Diabetes
- Being tested
- Sit-Stand workstation, Move
- Medical subject headings
- Obesity, Hypertension, Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sit-Stand workstationDevice
Installation of a sit-stand desk at work
MoveBehavioural
A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace
| Study group | Role | What they receive |
|---|---|---|
| Move | Active comparator | A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace. Receives: Behavioral: Move |
| Stand & Move | Experimental | Move intervention (A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace) plus the installation of a sit-stand workstation. Receives: Device: Sit-Stand workstation; Behavioral: Move |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
Measured: 1 year
Mean Change in Sitting Time at Work From Baseline to 12 Months
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
Measured: 1 year
Secondary outcomes (1)
Clustered Metabolic Risk Score From Baseline to 12 Months
Clustered metabolic risk score (fasting glucose, insulin, triglycerides, HDL-cholesterol, blood pressure); value at 12 months minus value at baseline; higher scores indicate better outcome. The Z-score for each component (fasting glucose, insulin, triglycerides, HDL-cholesterol, blood pressure) based on the baseline mean and standard deviation of the entire group was computed and summed for each participant (HDL z-score was subtracted rather than added). The sum of these z-scores represents the metabolic risk score.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Oct 2015 (estimated)
- Study start15 Jan 2016
- Primary completion15 Dec 2017
- Study completion15 Dec 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 630 participants (actual)
Sponsor and investigators
- Lead sponsor
- Arizona State University
- Sponsor type
- University, hospital or other
- Collaborators
- University of Minnesota
- Responsible party
- Sponsor
- Investigators
- Matthew P Buman, PhD, Principal investigator, Arizona State UniversityMark A Pereira, PhD, Principal investigator, University of Minnesota
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02566317
- Sponsor's protocol ID
- R01CA198971
- Status last verified
- Oct 2019
- First submitted
- 22 Sep 2015
- Last updated
- 11 Oct 2019
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Leonard KS, Larouche M, Mitchell NR, Rydell SA, Toledo MJ, Mullane SL, Hasanaj K, de Brito JN, Buman MP, Pereira MA. Maintenance effects of a multilevel workplace intervention to reduce sedentary time: twenty-four-month follow-up of the group randomized clinical trial 'Stand and Move at Work'. Int J Behav Nutr Phys Act. 2025 Apr 7;22(1):39. doi: 10.1186/s12966-025-01731-w.
PubMed 40197229Leonard KS, Mullane SL, Golden CA, Rydell SA, Mitchell NR, Koskan A, Estabrooks PA, Pereira MA, Buman MP. Qualitative comparative analysis of the implementation fidelity of a workplace sedentary reduction intervention. BMC Public Health. 2022 May 31;22(1):1086. doi: 10.1186/s12889-022-13476-3.
PubMed 35641923Pereira MA, Mullane SL, Toledo MJL, Larouche ML, Rydell SA, Vuong B, Feltes LH, Mitchell NR, de Brito JN, Hasanaj K, Carlson NG, Gaesser GA, Crespo NC, Oakes JM, Buman MP. Efficacy of the 'Stand and Move at Work' multicomponent workplace intervention to reduce sedentary time and improve cardiometabolic risk: a group randomized clinical trial. Int J Behav Nutr Phys Act. 2020 Oct 27;17(1):133. doi: 10.1186/s12966-020-01033-3.
PubMed 33109190Mullane SL, Toledo MJL, Rydell SA, Feltes LH, Vuong B, Crespo NC, Pereira MA, Buman MP. Social ecological correlates of workplace sedentary behavior. Int J Behav Nutr Phys Act. 2017 Aug 31;14(1):117. doi: 10.1186/s12966-017-0576-x.
PubMed 28859679Buman MP, Mullane SL, Toledo MJ, Rydell SA, Gaesser GA, Crespo NC, Hannan P, Feltes L, Vuong B, Pereira MA. An intervention to reduce sitting and increase light-intensity physical activity at work: Design and rationale of the 'Stand & Move at Work' group randomized trial. Contemp Clin Trials. 2017 Feb;53:11-19. doi: 10.1016/j.cct.2016.12.008. Epub 2016 Dec 7.
PubMed 27940181
Study at a glance
From the registry record, last updated by the sponsor on 11 Oct 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Stand & Move at Work: A Group Randomized Trial
- ClinicalTrials.gov ID
- NCT02566317
- Acronym / sponsor ID
- R01CA198971
- Conditions
- Obesity, Hypertension, Diabetes
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 630 participants (actual)
- Lead sponsor
- Arizona State UniversityUniversity, hospital or other
- Collaborators
- University of Minnesota
- Study start
- 15 Jan 2016 (actual)
- Primary completion
- 15 Dec 2017 (actual)
- Study completion
- 15 Dec 2018 (actual)
- First posted
- 2 Oct 2015 (estimated)
- Results
- Posted 11 Oct 2019
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A trial testing the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity in samples of office worksites.
Detailed description
With traditional approaches to increasing MVPA (moderate to vigorous physical activity) in the workplace being unsustainable due to the requirement of deliberate and dedicated time away from work, this group-randomized trial will test the efficacy of sit-stand workstations on decreasing sitting time and increasing light-intensity physical activity (LPA) in a highly generalizable sample of office worksites using a multi-level intervention with high potential for dissemination.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Move | Active comparator | Behavioral: MoveA multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace. |
| Stand & Move | Experimental | Device: Sit-Stand workstation, Behavioral: MoveMove intervention (A multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace) plus the installation of a sit-stand workstation. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (13 listed)
- Size: Small to moderate size worksite (20-60 employees)
- Schedule: >80% of employees full time
- Occupation: Seated office work, primarily computer- and- telephone-based work, little movement or walking
- Wellness environment: Not currently undergoing a wellness program aimed at increasing activity at work
- Workstations: Willing to have sit-stand workstations installed at a worksite
Key exclusion criteria (1 listed)
- contraindication to prolonged standing at work
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sit-Stand workstationInstallation of a sit-stand desk at work | Device | Stand & Move |
| MoveA multi-level individual, social, environmental, and organizational intervention targeting increases in light-intensity physical activity in the workplace | Behavioural | Move, Stand & Move |
Primary outcome
Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months
Time frame: 1 year
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
Mean Change in Sitting Time at Work From Baseline to 12 Months
Time frame: 1 year
Measured via 7d of activPAL accelerometry (value at 12 months minus value at baseline)
1 secondary outcome
Clustered Metabolic Risk Score From Baseline to 12 Months
Time frame: 1 year
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Oct 2019.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 40197229Leonard KS, Larouche M, Mitchell NR, Rydell SA, Toledo MJ, Mullane SL, Hasanaj K, de Brito JN, Buman MP, Pereira MA. Maintenance effects of a multilevel workplace intervention to reduce sedentary time: twenty-four-month follow-up of the group randomized clinical trial 'Stand and Move at Work'. Int J Behav Nutr Phys Act. 2025 Apr 7;22(1):39. doi: 10.1186/s12966-025-01731-w.
- Derived from this study: PubMed 35641923Leonard KS, Mullane SL, Golden CA, Rydell SA, Mitchell NR, Koskan A, Estabrooks PA, Pereira MA, Buman MP. Qualitative comparative analysis of the implementation fidelity of a workplace sedentary reduction intervention. BMC Public Health. 2022 May 31;22(1):1086. doi: 10.1186/s12889-022-13476-3.
- Derived from this study: PubMed 33109190Pereira MA, Mullane SL, Toledo MJL, Larouche ML, Rydell SA, Vuong B, Feltes LH, Mitchell NR, de Brito JN, Hasanaj K, Carlson NG, Gaesser GA, Crespo NC, Oakes JM, Buman MP. Efficacy of the 'Stand and Move at Work' multicomponent workplace intervention to reduce sedentary time and improve cardiometabolic risk: a group randomized clinical trial. Int J Behav Nutr Phys Act. 2020 Oct 27;17(1):133. doi: 10.1186/s12966-020-01033-3.
- Derived from this study: PubMed 28859679Mullane SL, Toledo MJL, Rydell SA, Feltes LH, Vuong B, Crespo NC, Pereira MA, Buman MP. Social ecological correlates of workplace sedentary behavior. Int J Behav Nutr Phys Act. 2017 Aug 31;14(1):117. doi: 10.1186/s12966-017-0576-x.
- Derived from this study: PubMed 27940181Buman MP, Mullane SL, Toledo MJ, Rydell SA, Gaesser GA, Crespo NC, Hannan P, Feltes L, Vuong B, Pereira MA. An intervention to reduce sitting and increase light-intensity physical activity at work: Design and rationale of the 'Stand & Move at Work' group randomized trial. Contemp Clin Trials. 2017 Feb;53:11-19. doi: 10.1016/j.cct.2016.12.008. Epub 2016 Dec 7.
- Individual participant dataSharing planned: Undecided
Related trials for Obesity
Not yet recruiting
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Lifestyle Intervention for Visceral Fat Reduction in Adults With Overweight or Obesity
Overweight, Obesity
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
RecruitingPhase 1/2
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Not yet recruitingPhase 3
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease
Not yet recruitingObservational study
A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Matthew P Buman, PhD principal investigator
Arizona State University
Mark A Pereira, PhD principal investigator
University of Minnesota
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Sit-Stand workstation and Move in people with Obesity and Hypertension, run by Arizona State University at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 13 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 11 Oct 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mean Change in Light-intensity Physical Activity at Work From Baseline to 12 Months (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02566317, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2019.